Efficacy and Safety of Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Checkpoint Inhibitors in Patients With Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis
| Autor: | Hong, X. ∗, †, 1, Zhang, Y. †, 1, Chi, Z. †, 1, Xu, Q. †, Lin, W. †, Huang, Y. †, Lin, T. |
|---|---|
| Zdroj: | In Clinical Oncology January 2024 36(1):e20-e30 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect